Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

28.48

-0.44 (-1.52%)

At close: Nov 19, 2025, 4:00 PM EST

27.50

-0.98 (-3.44%)

After-hours: Nov 19, 2025, 7:29 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Antisense Oligonucleotide	8.78M	Log In
Antisense Oligonucleotide Growth	-29.22%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.